GEMCITABINE, OXALIPLATIN AND CAPECITABINE (GEMOXEL) FOR PATIENTS WITH ADVANCED PANCREATIC ADENOCARCINOMA (APC). PRELIMINARY RESULTS OF AN ONGOING PHASE I/II TRIAL

被引：0
|
作者：
Hess, V. [1 ]
Pestalozzi, B. [2 ]
Ludwig, C. [3 ]
Winterhalder, R. [4 ]
Lohri, A. [5 ]
Jost, L. [6 ]
Widmer, L. [7 ]
Lee, L. [1 ]
Stillhart, P. [1 ]
Herrmann, R. [1 ]
机构：
[1] Univ Basel Hosp, CH-4031 Basel, Switzerland
[2] Univ Zurich Hosp, CH-8091 Zurich, Switzerland
[3] St Clara Hosp, Basel, Switzerland
[4] Kantonsspital Luzern, Luzern, Switzerland
[5] Kantonsspital Liestal, CH-4410 Liestal, Switzerland
[6] Kantonsspital Bruderholz, Bruderholz, Switzerland
[7] Onkozentrum Hirslanden, Zurich, Switzerland
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：181 / 181
页数：1
相关论文
共 50 条
  • [41] Biweekly oxaliplatin with gemcitabine and capecitabine in advanced gastrointestinal malignancies: A phase I study
    Tan, B. R.
    Brenner, W. S.
    Picus, J.
    Suresh, R.
    Sorcher, S.
    James, J. S.
    Fournier, C.
    Mcleod, H. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [42] Interim Analysis of a Phase II Clinical Trial of Induction Gemcitabine/Capecitabine followed by SABR in Borderline/Locally Advanced Pancreatic Adenocarcinoma
    Quan, K.
    Rajagopalan, M. S.
    Clump, D. A.
    Wegner, R. E.
    Burton, S.
    Flickinger, J. C.
    Stoller, R.
    Lembersky, B.
    Bahary, N.
    Zeh, H.
    Heron, D. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S48 - S49
  • [43] A Randomized Multicenter Trial of Capecitabine plus Oxaliplatin (CapOx) versus Capecitabine plus Gemcitabine (CapGem) versus Gemcitabine plus Oxaliplatin (GemOx) in the treatment of patients with advanced pancreatic cancer
    Golf, Alexander
    Hoehler, Thomas
    Seipelt, Gernot
    Mahlberg, Rolf
    Wein, Axel
    Hichhaus, Andreas
    Schmid, Birgit
    Boeck, Hans-Peter
    Hinke, Axel
    Boeck, Stefan
    Heinemann, Volker
    ANNALS OF ONCOLOGY, 2004, 15 : 243 - 243
  • [44] Phase II study of gemcitabine, capecitabine and cisplatin in patients with advanced pancreatic cancer.
    Chang, HM
    Kim, TW
    Ahn, JH
    Ryu, MH
    Lee, JS
    Kim, WK
    Kang, YK
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 368S - 368S
  • [45] Gemcitabine and oxaliplatin (GEMOX) as first-line chemotherapy in advanced biliary tract adenocarcinoma:: Preliminary results of a phase II study
    Rozzi, A.
    Corona, M.
    Nardoni, C.
    Petricola, F.
    Calabro, P.
    Lanzetta, G.
    ANNALS OF ONCOLOGY, 2007, 18 : 17 - 17
  • [46] A phase II trial of gemcitabine in combination with oxaliplatin and capecitabine in previously untreated metasetatic or recurrent pancreatic cancer.
    Sym, Sun Jin
    Hong, Junsik
    Jung, Minkyu
    Koo, Yang Seo
    Park, Yeon Ho
    Kim, Koen Kook
    Park, Jinny
    Cho, Eun Kyung
    Lee, Jae Hoon
    Shin, Dong Bok
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [47] Phase II trial of vatalinib in patients with advanced or metastatic pancreatic adenocarcinoma who failed gemcitabine therapy
    Dragovich, T.
    Laheru, D. A.
    Crowley, J. J.
    Smith, L. S.
    Seng, J.
    Burris, H. A., III
    Rosen, P. J.
    Von Hoff, D. D.
    Bolejack, V.
    Hidalgo, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [48] A phase I trial of Capecitabine plus Gemcitabine with radical radiation for locally advanced pancreatic cancer
    Michael, M.
    Price, T.
    Ngan, S. Y.
    Ganju, V.
    Strickland, A. H.
    Muller, A.
    Khamly, K.
    Milner, A. D.
    Dilulio, J.
    Matera, A.
    Zalcberg, J. R.
    Leong, T.
    BRITISH JOURNAL OF CANCER, 2009, 100 (01) : 37 - 43
  • [49] A phase I trial of Capecitabine+Gemcitabine with radical radiation for locally advanced pancreatic cancer
    M Michael
    T Price
    S Y Ngan
    V Ganju
    A H Strickland
    A Muller
    K Khamly
    A D Milner
    J Dilulio
    A Matera
    J R Zalcberg
    T Leong
    British Journal of Cancer, 2009, 100 : 37 - 43
  • [50] A phase II trial of oxaliplatin plus capecitabine (xelox) as second line therapy for patients with advanced pancreatic cancer.
    Xiong, H. Q.
    Wolff, R. A.
    Hess, K. R.
    Varadhachary, G. R.
    Blais, J. C.
    Abbruzzese, J. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 207S - 207S
12345